What is Spheryx?
Spheryx, Inc. operates at the intersection of advanced physics and industrial quality control. Its core technology, Total Holographic Characterization, enables the precise analysis of individual particles in complex fluids, a capability that is increasingly vital for modern manufacturing and research. By providing granular data on particle behavior, the company empowers its clients to optimize product development cycles, minimize material waste, and ensure rigorous quality assurance standards. The firm's market position is defined by its ability to deliver actionable insights that traditional light scattering methods often overlook, thereby enhancing competitive advantages for its enterprise-level partners in the semiconductor and pharmaceutical sectors.
How much funding has Spheryx raised?
Spheryx has raised a total of $642K across 2 funding rounds:
Debt
$141K
Stock/Share Issuance
$501K
Debt (2021): $141K with participation from PPP
Stock/Share Issuance (2026): $501K, investors not publicly disclosed
Key Investors in Spheryx
PPP
Public-Private Partnership
Undisclosed Investor
A strategic participant in the most recent equity issuance round.
What's next for Spheryx?
With this latest infusion of capital, Spheryx is well-positioned to scale its operational footprint and accelerate the commercial deployment of its holographic analysis systems. The company is expected to prioritize the expansion of its service offerings within the biologic pharmaceutical space, where the demand for precise particle characterization is reaching an inflection point. Furthermore, the strategic allocation of these funds will likely support the refinement of its semiconductor-grade monitoring tools, ensuring that the firm remains at the forefront of industrial innovation. As the company transitions into this next phase of growth, the focus will remain on deepening market penetration and establishing its technology as the industry standard for fluid-based particle analysis.
See full Spheryx company page
